메뉴 건너뛰기




Volumn 7, Issue 23, 2016, Pages 35466-35477

Multiple myeloma cancer stem cells

Author keywords

Drug resistance; MicroRNA; Myeloma stem cells; Signaling pathways; Surface marker

Indexed keywords

ABC TRANSPORTER; ALDEHYDE DEHYDROGENASE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

EID: 84973640880     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8154     Document Type: Article
Times cited : (53)

References (99)
  • 1
    • 84867158927 scopus 로고    scopus 로고
    • Molecular pathogenesis of multiple myeloma and its premalignant precursor
    • Kuehl WM and Bergsagel PL. Molecular pathogenesis of multiple myeloma and its premalignant precursor. The Journal of clinical investigation. 2012; 122:3456-3463
    • (2012) The Journal of clinical investigation , vol.122 , pp. 3456-3463
    • Kuehl, W.M.1    Bergsagel, P.L.2
  • 4
    • 34547106018 scopus 로고    scopus 로고
    • Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
    • Hideshima T, Mitsiades C, Tonon G, Richardson PG and Anderson KC. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nature reviews Cancer. 2007; 7:585-598
    • (2007) Nature reviews Cancer , vol.7 , pp. 585-598
    • Hideshima, T.1    Mitsiades, C.2    Tonon, G.3    Richardson, P.G.4    Anderson, K.C.5
  • 6
    • 84925230958 scopus 로고    scopus 로고
    • An oral proteasome inhibitor for multiple myeloma
    • Pratt G. An oral proteasome inhibitor for multiple myeloma. The Lancet Oncology. 2014; 15:1417-1418
    • (2014) The Lancet Oncology , vol.15 , pp. 1417-1418
    • Pratt, G.1
  • 7
    • 84908131467 scopus 로고    scopus 로고
    • Panobinostat for the treatment of multiple myeloma
    • Rajkumar SV. Panobinostat for the treatment of multiple myeloma. The Lancet Oncology. 2014; 15:1178-1179
    • (2014) The Lancet Oncology , vol.15 , pp. 1178-1179
    • Rajkumar, S.V.1
  • 9
    • 33846100356 scopus 로고    scopus 로고
    • A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
    • O'Brien CA, Pollett A, Gallinger S and Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007; 445:106-110
    • (2007) Nature , vol.445 , pp. 106-110
    • O'Brien, C.A.1    Pollett, A.2    Gallinger, S.3    Dick, J.E.4
  • 10
    • 0030789242 scopus 로고    scopus 로고
    • Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
    • Bonnet D and Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature medicine. 1997; 3:730-737
    • (1997) Nature medicine , vol.3 , pp. 730-737
    • Bonnet, D.1    Dick, J.E.2
  • 15
    • 67650632683 scopus 로고    scopus 로고
    • CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells
    • Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD, Jr., van Rooijen N and Weissman IL. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 2009; 138:286-299
    • (2009) Cell , vol.138 , pp. 286-299
    • Majeti, R.1    Chao, M.P.2    Alizadeh, A.A.3    Pang, W.W.4    Jaiswal, S.5    Gibbs, K.D.6    van Rooijen, N.7    Weissman, I.L.8
  • 17
    • 84871238560 scopus 로고    scopus 로고
    • CD19-CD45 low/-CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells
    • Kim D, Park CY, Medeiros BC and Weissman IL. CD19-CD45 low/-CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells. Leukemia. 2012; 26:2530-2537
    • (2012) Leukemia , vol.26 , pp. 2530-2537
    • Kim, D.1    Park, C.Y.2    Medeiros, B.C.3    Weissman, I.L.4
  • 19
    • 79551602468 scopus 로고    scopus 로고
    • Critical appraisal of the side population assay in stem cell and cancer stem cell research
    • Golebiewska A, Brons NH, Bjerkvig R and Niclou SP. Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell stem cell. 2011; 8:136-147
    • (2011) Cell stem cell , vol.8 , pp. 136-147
    • Golebiewska, A.1    Brons, N.H.2    Bjerkvig, R.3    Niclou, S.P.4
  • 20
    • 48349133869 scopus 로고    scopus 로고
    • Side population cells in human cancers
    • Wu C and Alman BA. Side population cells in human cancers. Cancer letters. 2008; 268:1-9
    • (2008) Cancer letters , vol.268 , pp. 1-9
    • Wu, C.1    Alman, B.A.2
  • 24
    • 0033570946 scopus 로고    scopus 로고
    • The proliferative potential of myeloma plasma cells manifest in the SCID-hu host
    • Yaccoby S and Epstein J. The proliferative potential of myeloma plasma cells manifest in the SCID-hu host. Blood. 1999; 94:3576-3582
    • (1999) Blood , vol.94 , pp. 3576-3582
    • Yaccoby, S.1    Epstein, J.2
  • 25
    • 8844264524 scopus 로고    scopus 로고
    • The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells
    • Yata K and Yaccoby S. The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia. 2004; 18:1891-1897
    • (2004) Leukemia , vol.18 , pp. 1891-1897
    • Yata, K.1    Yaccoby, S.2
  • 28
    • 84857473351 scopus 로고    scopus 로고
    • Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma
    • Trepel M, Martens V, Doll C, Rahlff J, Gosch B, Loges S and Binder M. Phenotypic detection of clonotypic B cells in multiple myeloma by specific immunoglobulin ligands reveals their rarity in multiple myeloma. PloS one. 2012; 7:e31998
    • (2012) PloS one , vol.7
    • Trepel, M.1    Martens, V.2    Doll, C.3    Rahlff, J.4    Gosch, B.5    Loges, S.6    Binder, M.7
  • 31
    • 84887611170 scopus 로고    scopus 로고
    • Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma
    • Hajek R, Okubote SA and Svachova H. Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma. British journal of haematology. 2013; 163:551-564
    • (2013) British journal of haematology , vol.163 , pp. 551-564
    • Hajek, R.1    Okubote, S.A.2    Svachova, H.3
  • 32
    • 84898930013 scopus 로고    scopus 로고
    • Concise review: Defining and targeting myeloma stem cell-like cells
    • Abe M, Harada T and Matsumoto T. Concise review: Defining and targeting myeloma stem cell-like cells. Stem cells. 2014; 32:1067-1073
    • (2014) Stem cells , vol.32 , pp. 1067-1073
    • Abe, M.1    Harada, T.2    Matsumoto, T.3
  • 34
    • 33645514001 scopus 로고    scopus 로고
    • A side order of stem cells: the SP phenotype
    • Challen GA and Little MH. A side order of stem cells: the SP phenotype. Stem cells. 2006; 24:3-12
    • (2006) Stem cells , vol.24 , pp. 3-12
    • Challen, G.A.1    Little, M.H.2
  • 37
    • 33744997203 scopus 로고    scopus 로고
    • Thalidomide in elderly patients with multiple myeloma
    • author reply 1977-1978
    • Kusumi E, Matsumura T, Yuji K, Tanaka Y and Kami M. Thalidomide in elderly patients with multiple myeloma. Lancet. 2006; 367:1977; author reply 1977-1978
    • (2006) Lancet , vol.367 , pp. 1977
    • Kusumi, E.1    Matsumura, T.2    Yuji, K.3    Tanaka, Y.4    Kami, M.5
  • 38
    • 0033546823 scopus 로고    scopus 로고
    • Low-dose thalidomide seems to be effective in multiple myeloma
    • Larkin M. Low-dose thalidomide seems to be effective in multiple myeloma. Lancet. 1999; 354:925
    • (1999) Lancet , vol.354 , pp. 925
    • Larkin, M.1
  • 39
    • 78650303860 scopus 로고    scopus 로고
    • Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
    • Cavo M, Tacchetti P, Patriarca F, Petrucci MT, Pantani L, Galli M, Di Raimondo F, Crippa C, Zamagni E, Palumbo A, Offidani M, Corradini P, Narni F, Spadano A, Pescosta N, Deliliers GL, et al. Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study. Lancet. 2010; 376:2075-2085
    • (2010) Lancet , vol.376 , pp. 2075-2085
    • Cavo, M.1    Tacchetti, P.2    Patriarca, F.3    Petrucci, M.T.4    Pantani, L.5    Galli, M.6    Di Raimondo, F.7    Crippa, C.8    Zamagni, E.9    Palumbo, A.10    Offidani, M.11    Corradini, P.12    Narni, F.13    Spadano, A.14    Pescosta, N.15    Deliliers, G.L.16
  • 41
    • 84950996666 scopus 로고    scopus 로고
    • Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
    • Franqui-Machin R, Wendlandt EB, Janz S, Zhan F and Tricot G. Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction? Oncotarget. 2015 1; 6:40496-506. doi: 10.18632/oncotarget.5800
    • (2015) Oncotarget , vol.1 , Issue.6 , pp. 40496-40506
    • Franqui-Machin, R.1    Wendlandt, E.B.2    Janz, S.3    Zhan, F.4    Tricot, G.5
  • 42
    • 0027976530 scopus 로고
    • Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrugresistant disease in multiple myeloma
    • Pilarski LM and Belch AR. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrugresistant disease in multiple myeloma. Blood. 1994; 83:724-736
    • (1994) Blood , vol.83 , pp. 724-736
    • Pilarski, L.M.1    Belch, A.R.2
  • 44
    • 0032821233 scopus 로고    scopus 로고
    • Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation
    • Rottenburger C, Kiel K, Bosing T, Cremer FW, Moldenhauer G, Ho AD, Goldschmidt H and Moos M. Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation. British journal of haematology. 1999; 106:545-552
    • (1999) British journal of haematology , vol.106 , pp. 545-552
    • Rottenburger, C.1    Kiel, K.2    Bosing, T.3    Cremer, F.W.4    Moldenhauer, G.5    Ho, A.D.6    Goldschmidt, H.7    Moos, M.8
  • 48
    • 84875583581 scopus 로고    scopus 로고
    • Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1
    • Hawley TS, Riz I, Yang W, Wakabayashi Y, Depalma L, Chang YT, Peng W, Zhu J and Hawley RG. Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1. American journal of hematology. 2013; 88:265-272
    • (2013) American journal of hematology , vol.88 , pp. 265-272
    • Hawley, T.S.1    Riz, I.2    Yang, W.3    Wakabayashi, Y.4    Depalma, L.5    Chang, Y.T.6    Peng, W.7    Zhu, J.8    Hawley, R.G.9
  • 50
    • 79955593909 scopus 로고    scopus 로고
    • Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform
    • Marcato P, Dean CA, Giacomantonio CA and Lee PW. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell cycle. 2011; 10:1378-1384
    • (2011) Cell cycle , vol.10 , pp. 1378-1384
    • Marcato, P.1    Dean, C.A.2    Giacomantonio, C.A.3    Lee, P.W.4
  • 51
    • 18744411547 scopus 로고    scopus 로고
    • Aplastic anaemia
    • Brodsky RA and Jones RJ. Aplastic anaemia. Lancet. 2005; 365:1647-1656
    • (2005) Lancet , vol.365 , pp. 1647-1656
    • Brodsky, R.A.1    Jones, R.J.2
  • 57
    • 67449113764 scopus 로고    scopus 로고
    • Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers
    • Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y and Noguchi S. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clinical cancer research. 2009; 15:4234-4241
    • (2009) Clinical cancer research , vol.15 , pp. 4234-4241
    • Tanei, T.1    Morimoto, K.2    Shimazu, K.3    Kim, S.J.4    Tanji, Y.5    Taguchi, T.6    Tamaki, Y.7    Noguchi, S.8
  • 62
    • 39749178390 scopus 로고    scopus 로고
    • Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo
    • Fleming HE, Janzen V, Lo Celso C, Guo J, Leahy KM, Kronenberg HM and Scadden DT. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell stem cell. 2008; 2:274-283
    • (2008) Cell stem cell , vol.2 , pp. 274-283
    • Fleming, H.E.1    Janzen, V.2    Lo Celso, C.3    Guo, J.4    Leahy, K.M.5    Kronenberg, H.M.6    Scadden, D.T.7
  • 65
    • 84923283486 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation
    • Hirata N, Yamada S, Shoda T, Kurihara M, Sekino Y and Kanda Y. Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation. Nature communications. 2014; 5:4806
    • (2014) Nature communications , vol.5 , pp. 4806
    • Hirata, N.1    Yamada, S.2    Shoda, T.3    Kurihara, M.4    Sekino, Y.5    Kanda, Y.6
  • 66
    • 84945573758 scopus 로고    scopus 로고
    • PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth
    • Sharma N, Nanta R, Sharma J, Gunewardena S, Singh KP, Shankar S and Srivastava RK. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth. Oncotarget. 2015; 6:32039-32060. doi: 10.18632/oncotarget.5055
    • (2015) Oncotarget , vol.6 , pp. 32039-32060
    • Sharma, N.1    Nanta, R.2    Sharma, J.3    Gunewardena, S.4    Singh, K.P.5    Shankar, S.6    Srivastava, R.K.7
  • 68
    • 17244376814 scopus 로고    scopus 로고
    • Wnt signalling in stem cells and cancer
    • Reya T and Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005; 434:843-850
    • (2005) Nature , vol.434 , pp. 843-850
    • Reya, T.1    Clevers, H.2
  • 69
    • 30544450976 scopus 로고    scopus 로고
    • WNT/betacatenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells
    • Hao J, Li TG, Qi X, Zhao DF and Zhao GQ. WNT/betacatenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Developmental biology. 2006; 290:81-91
    • (2006) Developmental biology , vol.290 , pp. 81-91
    • Hao, J.1    Li, T.G.2    Qi, X.3    Zhao, D.F.4    Zhao, G.Q.5
  • 73
    • 84886879974 scopus 로고    scopus 로고
    • Targeting hedgehog signaling in cancer: research and clinical developments
    • Xie J, Bartels CM, Barton SW and Gu D. Targeting hedgehog signaling in cancer: research and clinical developments. OncoTargets and therapy. 2013; 6:1425-1435
    • (2013) OncoTargets and therapy , vol.6 , pp. 1425-1435
    • Xie, J.1    Bartels, C.M.2    Barton, S.W.3    Gu, D.4
  • 74
    • 77950826827 scopus 로고    scopus 로고
    • Multiple myeloma: a paradigm for translation of the cancer stem cell hypothesis
    • Agarwal JR and Matsui W. Multiple myeloma: a paradigm for translation of the cancer stem cell hypothesis. Anticancer agents in medicinal chemistry. 2010; 10:116-120
    • (2010) Anticancer agents in medicinal chemistry , vol.10 , pp. 116-120
    • Agarwal, J.R.1    Matsui, W.2
  • 75
    • 84866365997 scopus 로고    scopus 로고
    • Molecular pathways: the hedgehog signaling pathway in cancer
    • McMillan R and Matsui W. Molecular pathways: the hedgehog signaling pathway in cancer. Clinical cancer research. 2012; 18:4883-4888
    • (2012) Clinical cancer research , vol.18 , pp. 4883-4888
    • McMillan, R.1    Matsui, W.2
  • 78
    • 84907276398 scopus 로고    scopus 로고
    • A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance
    • Liu Z, Xu J, He J, Zheng Y, Li H, Lu Y, Qian J, Lin P, Weber DM, Yang J and Yi Q. A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance. Blood. 2014; 124:2061-2071
    • (2014) Blood , vol.124 , pp. 2061-2071
    • Liu, Z.1    Xu, J.2    He, J.3    Zheng, Y.4    Li, H.5    Lu, Y.6    Qian, J.7    Lin, P.8    Weber, D.M.9    Yang, J.10    Yi, Q.11
  • 79
    • 1942425110 scopus 로고    scopus 로고
    • Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines
    • Nefedova Y, Cheng P, Alsina M, Dalton WS and Gabrilovich DI. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood. 2004; 103:3503-3510
    • (2004) Blood , vol.103 , pp. 3503-3510
    • Nefedova, Y.1    Cheng, P.2    Alsina, M.3    Dalton, W.S.4    Gabrilovich, D.I.5
  • 83
    • 41349095228 scopus 로고    scopus 로고
    • Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy
    • Nefedova Y, Sullivan DM, Bolick SC, Dalton WS and Gabrilovich DI. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood. 2008; 111:2220-2229
    • (2008) Blood , vol.111 , pp. 2220-2229
    • Nefedova, Y.1    Sullivan, D.M.2    Bolick, S.C.3    Dalton, W.S.4    Gabrilovich, D.I.5
  • 90
    • 84934300731 scopus 로고    scopus 로고
    • MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma
    • Du J, Liu S, He J, Liu X, Qu Y, Yan W, Fan J, Li R, Xi H, Fu W, Zhang C, Yang J and Hou J. MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma. Oncotarget. 2015; 6:14993-15007
    • (2015) Oncotarget , vol.6 , pp. 14993-15007
    • Du, J.1    Liu, S.2    He, J.3    Liu, X.4    Qu, Y.5    Yan, W.6    Fan, J.7    Li, R.8    Xi, H.9    Fu, W.10    Zhang, C.11    Yang, J.12    Hou, J.13
  • 91
    • 84919842021 scopus 로고    scopus 로고
    • MicroRNAs in cancer stem cells: current status and future directions
    • Chhabra R and Saini N. MicroRNAs in cancer stem cells: current status and future directions. Tumour biology. 2014; 35:8395-8405
    • (2014) Tumour biology , vol.35 , pp. 8395-8405
    • Chhabra, R.1    Saini, N.2
  • 92
    • 84950996666 scopus 로고    scopus 로고
    • Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
    • Franqui-Machin R, Wendlandt EB, Janz S, Zhan F and Tricot G. Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction? Oncotarget. 2015; 6:40496-40506. doi: 10.18632/oncotarget.5800
    • (2015) Oncotarget , vol.6 , pp. 40496-40506
    • Franqui-Machin, R.1    Wendlandt, E.B.2    Janz, S.3    Zhan, F.4    Tricot, G.5
  • 99
    • 21244463426 scopus 로고    scopus 로고
    • SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells
    • Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C and Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005; 121:1109-1121
    • (2005) Cell , vol.121 , pp. 1109-1121
    • Kiel, M.J.1    Yilmaz, O.H.2    Iwashita, T.3    Yilmaz, O.H.4    Terhorst, C.5    Morrison, S.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.